ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    facet.materialart.
    Unknown
    Pierce's disease of grapevines: isolation of the causal bacterium (1978)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1978-01-06
    Description: A Gram-negative, rod-shaped bacterium has been consistently isolated from grapevines with Pierce's disease. Grapevines inoculated with the bacterium developed Pierce's disease, and the bacterium was reisolated from the plants. The bacterium was serologically and ultrastructurallv indistinguishable from the one in naturally infected plants, and also indistinguishable from a bacterium isolated from almonds with almond leaf scorch disease.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Davis, M J -- Purcell, A H -- Thomson, S V -- New York, N.Y. -- Science. 1978 Jan 6;199(4324):75-7.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Plant Pathology, University of California, Berkeley, CA 94720, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/17569487" target="_blank"〉PubMed〈/a〉
    Keywords: Agglutination Tests ; Animals ; Cell Wall/ultrastructure ; Gram-Negative Bacteria/cytology/immunology/*isolation & ; purification/pathogenicity ; Hemiptera/microbiology ; Insect Vectors/microbiology ; Male ; Mice ; Plant Diseases/*microbiology ; Prunus/microbiology ; Rabbits ; Vitis/*microbiology
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 2
    facet.materialart.
    Unknown
    Physostigmine: improvement of long-term memory processes in normal humans (1978)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1978-07-21
    Description: Nineteen normal male subjects received 1.0 milligram of physostigmine or 1.0 milligram of saline by a slow intravenous infusion on two nonconsecutive days. Physostigmine significantly enhanced storage of information into long-term memory. Retrieval of information from long-term memory was also improved. Short-term memory processes were not significantly altered by physostigmine.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Davis, K L -- Mohs, R C -- Tinklenberg, J R -- Pfefferbaum, A -- Hollister, L E -- Kopell, B S -- New York, N.Y. -- Science. 1978 Jul 21;201(4352):272-4.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/351807" target="_blank"〉PubMed〈/a〉
    Keywords: Acetylcholine/physiology ; Adolescent ; Adult ; Alzheimer Disease/drug therapy ; Clinical Trials as Topic ; Humans ; Male ; Memory/*drug effects/physiology ; Memory, Short-Term/drug effects ; Physostigmine/*pharmacology/therapeutic use
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 3
    facet.materialart.
    Unknown
    Schizophrenic symptoms improve with apomorphine (1978)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1978-05-05
    Description: Eighteen chronic schizophrenic patients received subcutaneous doses of apomorphine, a dopamine receptor agonist, and of placebo in separate trials. A significant improvement in psychotic symptoms occurred after apomorphine compared to placebo. The results are interpreted as a consequence of presynaptic dopamine receptor activation by apomorphine with a subsequent decrease in dopamine-mediated neural transmission.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Tamminga, C A -- Schaffer, M H -- Smith, R C -- Davis, J M -- New York, N.Y. -- Science. 1978 May 5;200(4341):567-8.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/347574" target="_blank"〉PubMed〈/a〉
    Keywords: Apomorphine/pharmacology/*therapeutic use ; Chronic Disease ; Clinical Trials as Topic ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Humans ; Male ; Nerve Endings/drug effects ; Receptors, Dopamine/drug effects ; Schizophrenia/*drug therapy
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...